An association between ulcerative colitis and atopic dermatitis, diseases of impaired superficial barriers [4]

Journal of Investigative Dermatology

Volumn 123, Issue 5, 2004, Pages 999-1000

  Niwa, Yukie ^a   Sumi, Hajime ^b   Akamatsu, Hirohiko ^c  

^a Niwa Institute for Immunology   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATOPIC DERMATITIS; CROHN DISEASE; DISEASE ASSOCIATION; GENETIC LINKAGE; HUMAN; IMMUNOPATHOLOGY; JAPAN; LETTER; MUCOSA; MUCOSA INFLAMMATION; PERMEABILITY BARRIER; PREVALENCE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 6344274865     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23462.x     Document Type: Letter

References (16)

1. Bowcock AM, Cookson WO: The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 13 (Spec No. 1):R43-R55, 2004
2. Brophy S, Pavy S, Lewis R et al: Inflammatory eye, skin, and bowel disease in spondyloarthritis: Genetic, phenotypic, and environmental factors. J Rheumatol 28:2667-2673, 2001
3. Conn HO, Snyder N, Atterbury CE: The Berkson bias in action. Yale J Biol Med 52:141-147, 1979
4. Cookson WO, Ubhl B, Lawrence R, et al: Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 27:372-373, 2001
5. Giallourakis C, Stoll M, Miller K, et al: IBD5 is a general risk factor for inflammatory bowel disease: Replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 73:205-211, 2003
6. Inoue S, Matsumoto T, Iida M, Mizuno M, Kuroki F, Hoshika K, Shimizu M: Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: Correlation with disease activity. Am J Gastroenterol 94: 2441-2446, 1999
7. Morita N, Toki S, Hirohashi T, et al: Incidence and prevalence of Inflammatory bowel disease in Japan: Nationwide epidemiological survey during the year 1991. J Gastroenterol 30 (Suppl. 8):1-4, 1995
8. Niwa Y, Sumi H, Kawahira K, Terashima T, Nakamura T, Akamatsu H: Protein oxidative damage in the stratum corneum: Evidence for a link between environmental oxidants and the changing prevalence and nature of atopic dermatitis in Japan. Br J Dermatol 149:248-254, 2003
9. Ogawa H, Yoshiike T: A speculative view of atopic dermatitis: Barrier dysfunction in pathogenesis. J Dermatol Sci 5:197-204, 1993
10. Pugh SM, Rhodes J, Mayberry JF, Roberts DL, Heatley RV, Newcombe RG: Atopic disease in ulcerative colitis and Crohn's disease. Clin Allergy 9:221-223, 1979
11. Sawa Y, Oshitani N, Adachi K, Higuchi K, Matsumoto T, Arakawa T: Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease. Int J Mol Med 11:175-179, 2003
12. Taieb A: Hypothesis: From epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 41:177-180, 1999
13. Umeki S: Allergic cycle: Relationships between asthma, allergic rhinitis, and atopic dermatitis. J Asthma 31:19-26, 1994
14. Wild GE, Rioux JD: Genome scan analyses and positional cloning strategy in IBD: Successes and limitations. Best Pract Res Clin Gastroenterol 18:541-553, 2004
15. Yao T, Matsui T, Hiwatashi N: Crohn's disease in Japan: Diagnostic criteria and epidemiology. Dis Colon Rectum 43:385-393, 2000
16. Yoshida Y, Murata Y: Inflammatory bowel disease in Japan: Studies of epidemiology and etiopathogenesis. Med Clin North Am 74:67-90, 1990